Karuniawati A., Pasaribu AP., Lazarus G., Irawany V., Nusantara DU., Sinto R., Suwarti None., Nasution MJ., Ferawati None., Lubis MR., Nurfitri E., Mutiara M., Arifin H., Hely H., Putri PAD., Pradipta A., Susanto AP., Kumaheri MA., Bonifacius None., Da Costa Y., Bogh C., Safari D., Lidia K., Malewa HI., Nuraeni N., Zanjabila S., Rahardjani M., Dewi FA., Wulandari F., Subekti D., Surendra H., Baird JK., Shankar AH., Hamers RL.

BACKGROUND: Limited data exist from southeast Asia on the impact of SARS-CoV-2 variants and inactivated vaccines on disease severity and death among patients hospitalised with COVID-19. METHODS: A multicentre hospital-based prospective cohort was enrolled from September 2020 through January 2023, spanning pre-delta, delta, and omicron periods. The participant hospitals were conveniently sampled based on existing collaborations, site willingness and available study resources, and included six urban and two rural general hospitals from East Nusa Tenggara, Jakarta, and North Sumatra provinces. Factors associated with severe disease and day-28 mortality were examined using logistic and Cox regression. FINDINGS: Among 822 participants, the age-adjusted percentage of severe disease was 26.8% (95% CI 22.7-30.9) for pre-delta, 50.1% (44.0-56.2) for delta, and 15.2% (9.7-20.7) for omicron. The odds of severe disease were 64% (18-84%) lower for omicron than delta (p

Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort study.

DOI

Type

Journal

Publication Date

Volume

Keywords